United BioSource

Healthrageous, United BioSource, Boehringer Ingelheim launch SMART digital diabetes study

Friday, July 19, 2013

Healthrageous, a digital health management company, and pharmaceutical company Boehringer Ingelheim have launched the SMART study with United BioSource (UBC) to evaluate a digital technology enabled self-management solution to potentially improve the health status of people with type 2 diabetes. The goal of the solution is to leverage technology in a way that makes the personalized journey of self-managing diabetes easier for patients to self-manage their disease.

[Read More]